BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design
Top Cited Papers
Open Access
- 29 November 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 10, 2806
- https://doi.org/10.3389/fimmu.2019.02806
Abstract
The Bacillus Calmette-Guérin (BCG) is a live attenuated tuberculosis vaccine that has the ability to induce non-specific cross-protection against pathogens that might be unrelated to the target disease. Vaccination with BCG reduces mortality in newborns and induces an improved innate immune response against microorganisms other than Mycobacterium tuberculosis, such as Candida albicans and Staphylococcus aureus. Innate immune cells, including monocytes and natural killer (NK) cells, contribute to this non-specific immune protection in a way that is independent of memory T or B cells. This phenomenon associated with a memory-like response in innate immune cells is known as “trained immunity.” Epigenetic reprogramming through histone modification in the regulatory elements of particular genes has been reported as one of the mechanisms associated with the induction of trained immunity in both, humans and mice. Indeed, it has been shown that BCG vaccination induces changes in the methylation pattern of histones associated with specific genes in circulating monocytes leading to a “trained” state. Importantly, these modifications can lead to the expression and/or repression of genes that are related to increased protection against secondary infections after vaccination, with improved pathogen recognition and faster inflammatory responses. In this review, we discuss BCG-induced cross-protection and acquisition of trained immunity and potential heterologous effects of recombinant BCG vaccines.Keywords
Funding Information
- Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica (1170694, 1190830, 1190864)
- Comisión Nacional de Investigación Científica y Tecnológica
This publication has 144 references indexed in Scilit:
- Trichostatin A Promotes the Generation and Suppressive Functions of Regulatory T CellsJournal of Immunology Research, 2013
- Long-Lived Memory B-Cell Responses following BCG VaccinationPLOS ONE, 2012
- Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytesProceedings of the National Academy of Sciences of the United States of America, 2012
- Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 DiabetesPLOS ONE, 2012
- Dual Neonate Vaccine Platform against HIV-1 and M. tuberculosisPLOS ONE, 2011
- Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Guérin Vaccination of NewbornsAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Gene-specific control of the TLR-induced inflammatory responseClinical Immunology, 2009
- Epigenetic regulation of dendritic cell–derived interleukin-12 facilitates immunosuppression after a severe innate immune responseBlood, 2008
- Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Elicits Human Immunodeficiency Virus Type 1 Envelope-Specific T Lymphocytes at Mucosal SitesClinical and Vaccine Immunology, 2007
- Chromatin Modifications and Their FunctionCell, 2007